Exagen Inc. Reports First Quarter 2022 Results
11 mai 2022 16h05 HE
|
Exagen Inc.
SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2022. ...
National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board
10 déc. 2019 08h10 HE
|
Exagen, Inc.
SAN DIEGO, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers
24 avr. 2019 09h55 HE
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, April 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., a leader in helping rheumatologist and their patients in the diagnosis, prognosis, and management of chronic...
JEFFREY THOMAS ELLIOTT, CFA Joins Exagen’s Board of Directors
26 mars 2019 08h45 HE
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, March 26, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
Exagen and the Lupus Foundation of America Partner on New Initiative to Reduce the Time to an Accurate Lupus Diagnosis
26 févr. 2019 09h58 HE
|
Exagen Diagnostics, Inc.
San Diego, CA and Washington, DC, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Exagen, a life science company serving the rheumatology specialty, and the Lupus Foundation of America, the national force devoted...
Exagen Points the Way for Patients with Difficult-to-Diagnose Disease
02 mai 2018 09h55 HE
|
Exagen Diagnostics, Inc.
San Diego, Ca and Albuquerque, NM, May 02, 2018 (GLOBE NEWSWIRE) -- May is “Lupus Awareness Month” and according to the Lupus Foundation of America, polls show that some two thirds of Americans...